EGFR 37 KDA FRAGMENT AS CANCER MARKER

摘要

The present invention relates to the presence of a 37KDa epidermal growth factor receptor (EGFR) fragment in the urine of patients with transitional cell carcinoma of the bladder. The presence of the 37KDa EGFR fragment in urine can be ascertained using an antibody. The presence of the 37KDa EGFR fragment in the urine of patients can be a test for the presence of prostate cancer and can therefore be used as a general screen for health in the genitourinary area.